CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.
Also called NCT02458560
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 203 participants
- Sponsor
- Registry
-
NCT02458560
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Denmark, France, Germany, Italy, Netherlands, New Zealand, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02458560. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2016-08-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve
- Condition
- Aortic Valve Disease
- Intervention (Device)
- Edwards CENTERA Self-Expanding Transcatheter Heart Valve
- Lead sponsor
- Edwards Lifesciences
- Collaborator
- Medstar Health Research Institute
- Collaborator
- European Cardiovascular Research Center
- Collaborator
- University of British Columbia
Record details
- Record id
cardio:ct-nct02458560- Content hash
079d9bf75abfa514e07b2d28af1ff068843ddf024466261130c6285eecc649da